Sjögren’s disease (SjD) is a chronic systemic autoimmune disease that commonly affects the glands that make tears and saliva. Persistent dry eyes and dry mouth are hallmark symptoms, but Sjögren’s can also cause profound fatigue, pain, nerve problems, gland swelling, and inflammation in organs throughout the body. Symptoms range from mild to life-changing. A personalized care plan can protect the eyes and teeth, relieve dryness, control inflammation, monitor complications, and help people maintain daily function and quality of life.
Sjögren’s is more than a dryness disorder. It is an autoimmune disease that can affect the whole body.
The immune system normally protects the body from infection. In Sjögren’s disease, immune activity mistakenly targets healthy tissue, particularly moisture-producing glands called exocrine glands.
The lacrimal glands make tears, and the salivary glands make saliva. When these glands become inflamed or damaged, the eyes may feel gritty, burning, or painfully dry, and the mouth may feel sticky or cotton-like. Dryness can also affect the nose, throat, airways, skin, and genital tissues.
Sjögren’s can extend beyond the glands. Some people experience joint or muscle pain, disabling fatigue, brain fog, headaches, reflux, neuropathy, dysautonomia, rashes, or organ inflammation. Symptoms and severity vary widely, and test results do not always match how ill a person feels.
Sjögren’s may occur on its own or alongside another autoimmune disease, such as rheumatoid arthritis, lupus, systemic sclerosis, autoimmune thyroid disease, or inflammatory myositis. Each autoimmune condition should be recognized and treated according to its own effects.
There is currently no cure. Treatment focuses on protecting moisture-sensitive tissues, relieving symptoms, controlling systemic inflammation when present, preventing complications, and supporting daily life.
Population statistics cannot predict one person’s disease course. Regular monitoring and early evaluation of new symptoms are important.
Sjögren’s affects people across racial, ethnic, geographic, and socioeconomic groups, but research participation and access to specialty care have not been evenly distributed. This limits what is known about prevalence, symptom patterns, and treatment response in many communities.
Diagnosis may be delayed when:
Equitable care includes culturally responsive communication, accessible specialty referrals, affordable oral and eye care, interpreter services, reproductive counseling, disability support, and treatment plans that reflect the patient’s daily responsibilities and financial realities.
Every patient deserves to have systemic symptoms taken seriously, including when dryness is mild or antibody tests are negative.
The exact cause of Sjögren’s disease is unknown. Researchers believe it develops through a combination of inherited susceptibility, immune-system changes, hormones, and environmental triggers.
Factors associated with increased likelihood include:
Risk factors do not equal a diagnosis. Many people with Sjögren’s have no known family history or identifiable trigger, and the disease is never the patient’s fault.
Symptoms can involve moisture-producing glands, the nervous system, joints, muscles, blood vessels, and internal organs. They may be constant or fluctuate over time. Sjögren’s symptoms are often invisible and unpredictable. A person may look well while managing severe eye pain, mouth dryness, exhaustion, neuropathy, dizziness, or cognitive difficulty.
Call 911 or seek emergency care for:
Contact a medical professional urgently for:
Do not assume severe symptoms are simply a Sjögren’s flare. Infection, eye injury, neurologic disease, blood clots, organ inflammation, and medication reactions may need immediate treatment.
Symptoms are not a reflection of motivation or resilience. Treatment, accommodations, pacing, and support can help people remain involved in the roles and activities that matter to them.
A flare is a period when symptoms or immune activity increase. Flares may cause greater dryness, more fatigue, gland swelling, joint or muscle pain, neuropathy, rashes, cognitive difficulty, or organ-related symptoms.
Remission means disease activity is very low or inactive by clinical measures. Some people continue to have dryness, nerve damage, or fatigue even when active inflammation is controlled because gland or tissue damage may persist.
Signs that may suggest a flare:
Contact the care team when symptoms are new, severe, persistent, or different from prior flares. Fever, one-sided gland swelling, severe eye symptoms, breathing changes, jaundice, blood in the urine, or rapid neurologic changes require prompt evaluation for infection or organ disease.
Diagnosis may require repeated assessment over time. Persistent symptoms deserve follow-up even after an initially incomplete or negative evaluation.
No single test diagnoses every case. Clinicians combine symptoms, objective dryness testing, blood work, salivary gland assessment, examination findings, and the possibility of other conditions.
A rheumatologist often coordinates the evaluation, with important contributions from ophthalmology, dentistry or oral medicine, and other specialists.
Diagnosis may include:
The 2016 ACR/EULAR classification criteria are often used to identify people for research and can support clinical diagnosis. They are not a substitute for a clinician’s judgment, especially in children, seronegative patients, early disease, or people with prominent systemic symptoms.
Imaging can support the diagnosis and identify complications, but normal imaging does not exclude early or gland-limited disease.
Treatment is tailored to the symptoms and organs involved. Many people need a combination of dryness care, preventive dental and eye treatment, rehabilitation, and medication for systemic disease.
Treatment goals include:
As of July 2026, no medication is FDA-approved specifically to treat systemic Sjögren’s disease as a whole. Several medicines are approved for dry eye or dry mouth, and immune-modifying treatments may be used off-label for selected systemic manifestations.
The care plan should be based on objective findings, symptom burden, organ risk, pregnancy goals, other autoimmune diseases, and the patient’s priorities. A medicine that helps arthritis may not improve dryness or fatigue, and symptom-relief products do not necessarily control systemic inflammation.
Never stop corticosteroids or immune-suppressing medicine suddenly. Discuss infection, vaccination, surgery, pregnancy, and medication access with the care team.
Procedures address specific damage or symptoms. They do not eliminate the underlying autoimmune disease.
General safety guidance
Supplements should support—not replace—eye care, dental prevention, prescribed treatment, exercise, sleep care, and organ monitoring.
Emerging does not mean proven or approved. Clinical-trial participation should include a clear discussion of risks, alternatives, travel, cost, reproductive precautions, and long-term follow-up.
Daily care focuses on protecting moisture-sensitive tissues, managing limited energy, reducing complications, and staying engaged in meaningful activities.
Sjögren’s management often involves many small actions throughout the day: eye drops, hydration, oral care, medication, pacing, and monitoring symptoms. That workload is real and can be exhausting.
A sustainable routine may include:
Self-management should not require perfection. The care plan should fit the patient’s life and remain flexible during flares.
No specific diet cures Sjögren’s. A balanced eating pattern can support heart, bone, muscle, oral, and digestive health.
Helpful foundations:
Make dry foods easier to swallow:
Protect the mouth:
Digestive symptoms: Reflux, nausea, constipation, diarrhea, or slow digestion may require individualized changes. Highly restrictive diets can cause nutrient deficiencies and should be supervised by a registered dietitian.
Regular movement supports circulation, muscle strength, joint stability, sleep, mood, bone health, and autonomic conditioning.
Include:
During a flare:
A physical therapist can create a plan for joint pain, weakness, neuropathy, balance problems, or dysautonomia.
People with Sjögren’s can have healthy pregnancies, but planning is important because disease activity, medication, and certain antibodies can affect pregnancy care.
Before pregnancy:
Anti-SSA/Ro and anti-SSB/La antibodies: These antibodies can cross the placenta. Most pregnancies are not affected, but there is a small risk of neonatal lupus and congenital heart block. A maternal-fetal medicine specialist may recommend serial fetal cardiac monitoring during the middle portion of pregnancy.
Medication planning: Hydroxychloroquine is often continued when clinically appropriate and may reduce certain pregnancy risks. Methotrexate, mycophenolate, cyclophosphamide, and leflunomide require specific pregnancy precautions. Do not stop or start medicine without specialist guidance.
During and after pregnancy: Monitor disease symptoms, blood pressure, fetal growth, and organ function as recommended. Plan postpartum treatment, breastfeeding-compatible medication, sleep support, hydration, and infant-care adaptations before delivery.
Fertility, contraception, and inclusive care: Active illness, age, medication, pain, and vaginal dryness may affect family planning. Counseling should include all people who may become pregnant and relevant medication review for sperm-producing partners. Transgender and nonbinary patients deserve reproductive care that respects their identity and goals.
Sjögren’s may qualify as a disability when symptoms substantially limit major life activities. In the United States, the Americans with Disabilities Act may require eligible employers to provide reasonable accommodations, and the Family and Medical Leave Act may offer protected leave to eligible workers.
Possible accommodations include:
Document how symptoms affect essential tasks, including fatigue, vision fluctuation, cognitive function, speech, swallowing, pain, and orthostatic symptoms.
The Job Accommodation Network (JAN) provides free, confidential guidance. Employment and disability rules vary, so legal or benefits advice may be needed for individual situations.
Emotional well-being is part of whole-person Sjögren’s care. Chronic dryness, pain, fatigue, cognitive symptoms, and uncertainty can place a significant burden on mental health.
Depression and anxiety are common in people living with Sjögren’s. Emotional distress does not mean the disease is psychological. Sjögren’s is a physical autoimmune condition, and mental health symptoms may develop alongside inflammation, chronic pain, sleep disruption, diagnostic delay, disability, or loss of valued roles.
Mental health treatment can improve coping, sleep, communication, relationships, treatment follow-through, and quality of life. Support may include counseling, medication, peer connection, pain-management strategies, and practical help with work or finances.
Some medicines used for depression, anxiety, allergies, sleep, or bladder symptoms can worsen dryness. Mental health and rheumatology clinicians can work together to select treatment that balances benefits and side effects.
Addressing pain, sleep, inflammation, oral health, financial stress, and social connection can be as important as treating mood symptoms directly.
If you are thinking about suicide or self-harm, call or text 988 in the United States for the 988 Suicide & Crisis Lifeline. If you are in immediate danger, call 911.
Rate each symptom from 1 (mild) to 5 (severe). Bring this filled out to your appointments — it helps your provider see patterns and adjust your care.
This guide is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for guidance specific to your situation.
